CrossRef Metabolic Reprogramming Nanoplatform for Broad-Spectrum Lactate Suppression to Reverse High Intensity Focused Ultrasound-Induced Immunosuppression in Hepatocellular Carcinoma Therapy Zeyan Huang, Yi Lin, Rui Tang, Qi Wang, Nianhong Wu, Li Wan, Pan Li, Ju Huang ACS Nano .2026
Record what you told the patient, why you made your clinical decision, and any referrals you suggested
Oral semaglutide is not FDA-approved for weight management as a primary indication
There is a higher risk of gallstones, more likely linked to weight loss rather than the drug itself
Your health and comfort are our top priorities, and we are committed to ensuring you experience the relief and support you need during your GLP-1 therapy journey